Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H19N3OS.ClH |
Molecular Weight | 325.857 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)C(=O)NC1=CC=CC(=C1)[C@H]2CN3CCSC3=N2
InChI
InChIKey=FXYKKPLSQTYWRY-BTQNPOSSSA-N
InChI=1S/C15H19N3OS.ClH/c1-10(2)14(19)16-12-5-3-4-11(8-12)13-9-18-6-7-20-15(18)17-13;/h3-5,8,10,13H,6-7,9H2,1-2H3,(H,16,19);1H/t13-;/m1./s1
Molecular Formula | C15H19N3OS |
Molecular Weight | 289.396 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: Description was created based on several sources, including https://books.google.ru/books?id=nq6Zeo5vng8C&pg=PA5144&lpg=PA5144&dq=BUTAMISOLE retrieved from Molecular Biochemistry and Physiology of Helminth Neuromuscular Systems
edited by David Halton, p.5144
Curator's Comment: Description was created based on several sources, including https://books.google.ru/books?id=nq6Zeo5vng8C&pg=PA5144&lpg=PA5144&dq=BUTAMISOLE retrieved from Molecular Biochemistry and Physiology of Helminth Neuromuscular Systems
edited by David Halton, p.5144
Butamisole is an injectable imidazothiazoles anthelmintic. In dogs it is used for the treatment of infections with whipworms (Trichuris vulpis ), and the hookworm (Ancylostoma caninum ). Nicotinic acetylcholine receptor agonist. Acts as agonist at nicotinic Ach receptor of nematode à ganglionic stimulation causes sustained muscle contraction initially followed by depolarising neuro muscular blockade which in turn leads to spastic paralysis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1884 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Butamisole Approved UseIndications for use. For the treatment of infections with whipworms (Trichuris vulpis), and the hookworm (Ancylostoma caninum). |
PubMed
Title | Date | PubMed |
---|---|---|
The efficacy and safety of injectable butamisole in dogs. | 1979 Apr |
|
Critical test evaluation of butamisole against gastrointestinal parasites of horses and ponies. | 1979 Jan |
|
Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans. | 2000 |
Patents
Sample Use Guides
Dogs: Administer 0.1 mg per pound of body weight by subcutaneous injection. In problem cases, retreatment for whipworms may be necessary in approximately 3 months. For hookworms, a second injection should be given 21 days after the initial treatment.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11113327
Butamisole was without agonist actions on either alpha7 or ACR-16 chicken nicotinic receptors in the range 10nM-1mM. However, butamisole (pIC(50)=4.9 for both alpha7 and ACR-16) antagonized responses of both alpha7 and ACR-16 receptors to acetylcholine. Application of butamisole
in the concentration range 0.1 um-100 um for 30 s prior
to application of 1 mM ACh in the continued presence of
butamisole resulted in a dose-dependent reduction in the
ACh current amplitude recorded from both receptors.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:37:20 GMT 2023
by
admin
on
Fri Dec 15 17:37:20 GMT 2023
|
Record UNII |
QGM18599H5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 522.234
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
76964744
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY | |||
|
DTXSID30969535
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY | |||
|
54400-62-3
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY | |||
|
m1048
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
C020238
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110807
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY | |||
|
QGM18599H5
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY | |||
|
C79919
Created by
admin on Fri Dec 15 17:37:20 GMT 2023 , Edited by admin on Fri Dec 15 17:37:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |